MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-33-0046060
Bioaltus Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹117.77 Cr
▲ 26% YoY
Net profit · FY 2025
₹10.21 Cr
Net margin 8.7%
EBITDA · FY 2025
₹14.78 Cr
EBITDA margin 12.5%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹92.85 Lakh
Issued & subscribed
Open charges
₹65 Cr
Satisfied ₹15.72 Cr
Company age
12 yrs
Est. 2014
Employees · EPFO
33
Provident fund records
About Bioaltus Pharmaceuticals Private Limited
Data last updated:
Bioaltus Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74900MH2014PTC254786. Its GSTIN is 27AAFCB8840D1ZQ (Maharashtra). The company holds 5 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹92.85 Lakh. It is led by directors Ankit Varshney (Whole-Time Director) and Gopinath Ramankutty Nair (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹117.77 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹10.21 Cr (net margin 8.7%) and EBITDA of ₹14.78 Cr (EBITDA margin 12.5%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 17% over five years.
The company has about 33 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Bioaltus. As per MCA filings, the company has open charges of ₹65 Cr and satisfied charges of ₹15.72 Cr on record. Court records list 5 cases involving the company, including 3 filed by the company and 2 filed against it; 1 case is pending. The company has 6 deals on record (2 rights issues, 2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹7.77 Cr; the latest was in December 2021. Its 9 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 5 larger and 4 smaller; the largest is M J Biopharm Private Limited with revenue of ₹119.1 Cr. The company has 14 MSME Form 1 returns on record between 2019 and 2024, listing 3,547 overdue payments to 91 micro and small suppliers.
Bioaltus Pharmaceuticals Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0046060). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website bioaltus.com.
Company details
CIN U74900MH2014PTC254786
Registration Number 254786
Incorporation Date 21 March 2014
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-33-0046060
Recognitions & Rankings of Bioaltus Pharmaceuticals
Contact details
Bioaltus Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its website is bioaltus.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFirst Floor Office No. 25 – 28 Tl 5 Morning Glory Tropical Lagoon Phase III Kavesar Ghodb, Under Road, Thane, Maharashtra, India – 400615
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Bioaltus Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Bioaltus Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Bioaltus Pharmaceuticals operates one associated brand: Bioaltus. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provides contract manufacturing and pharmaceutical products for medical fields like diabetology and cardiology. | bioaltus.com |
Business activity
The main business activity of Bioaltus Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Bioaltus Pharmaceuticals Private Limited, buy the company report.
Financials of Bioaltus Pharmaceuticals Private Limited
FY 2025 filings availableBioaltus Pharmaceuticals Private Limited reported revenue of ₹117.77 Cr (up 26% YoY) for FY 2025.
Revenue · FY 2025
₹117.77 Cr ▲ 26%
Net profit · FY 2025
₹10.21 Cr margin 8.7%
EBITDA · FY 2025
₹14.78 Cr margin 12.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 26%
3 years · compounded
▲ 14%
5 years · compounded
▲ 17%
EBITDA CAGR growth
1 year
▲ 101%
3 years · compounded
▲ 79%
5 years · compounded
▲ 32%
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 26% growth in the latest year. EBITDA rose 101% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.78 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.21 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.5% | ||||
| Net Profit Margin | 8.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Bioaltus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Bioaltus Pharmaceuticals Private Limited
Bioaltus Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankit Varshney Also directs: Bioaltus Lifesciences Private Limited | Whole-Time Director | 21 Mar 2014 | 12 Years 7 Months | Current |
| Gopinath Ramankutty Nair Also directs: Bioaltus Lifesciences Private Limited | Whole-Time Director | 18 Aug 2014 | 12 Years 2 Months | Current |
Peer comparison
Bioaltus Pharmaceuticals Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| M J Biopharm Private Limited | ₹119.1 Cr (FY 2017) | 9.0% | Mumbai, Maharashtra, India | |||
| Pell Tech Health Care Private Limited | ₹118.72 Cr (FY 2025) | 16.0% | Thane, Maharashtra, India | |||
| Ronak Healthcare Private Limited | ₹118.43 Cr (FY 2025) | 79.0% | Vadodara, Gujarat, India | |||
| Zen Pharma Private Limited | ₹118.25 Cr (FY 2022) | 24.0% | Mumbai, Maharashtra, India | |||
| Anglo-French Drugs & Industries Limited | ₹117.99 Cr (FY 2025) | 18.0% | Mumbai, Maharashtra, India | |||
| Bioaltus Pharmaceuticals Private Limitedthis company | ₹117.77 Cr (FY 2025) | ₹10.21 Cr | 8.7% | 26.0% | 33 | Thane, Maharashtra, India |
| Westcoast Pharmaceutical Works Limited | ₹117.56 Cr (FY 2024) | -3.0% | Ahmedabad, Gujarat, India | |||
| Crius Life Sciences Private Limited | ₹116.77 Cr (FY 2025) | 3.0% | Nalagarh, Himachal Pradesh, India | |||
| Kerala State Drugs and Pharmaceuticals Ltd | ₹116.23 Cr (FY 2024) | 41.0% | Alappuzha, Kerala, India | |||
| Ar-Ex Laboratories Private Limited | ₹115.46 Cr (FY 2025) | 16.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Bioaltus Pharmaceuticals Private Limited, buy the company report.
Auditor
Bioaltus Pharmaceuticals Private Limited is audited by S A H A G & ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S A H A G & ASSOCIATES | FY 2024 | 014326C |
Shareholding
The shareholding of Bioaltus Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Bioaltus Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹65 Cr
Satisfied charges
₹15.72 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 May 2025 | 101107796 | Hdfc Bank Limited | ₹65 Cr | Open | |
| 31 Dec 2022 | 100673869 | State Bank of India | ₹7.5 Cr | Satisfied | |
| 13 Jan 2022 | 100532554 | Others | ₹49.98 Lakh | Satisfied | |
| 19 May 2020 | 100337501 | Others | ₹4 Cr | Satisfied | |
| 28 Sep 2018 | 100217713 | Others | ₹3 Cr | Satisfied |
To see the full charge records of Bioaltus Pharmaceuticals Private Limited, buy the company report.
Total charge records: 7 View all charges
Deals & funding
Bioaltus Pharmaceuticals Private Limited has 6 deals on record (2 rights issues, 2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹7.77 Cr; the latest was in December 2021.
Total deals
6
Rights issues
2
Funding rounds
2
Secondary share transfers
2
Disclosed funding
₹7.77 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2021 | Funding round | ₹7.48 Cr | Investors: an individual |
| Jan 2021 | Rights issue | ₹15 Lakh | Investors: 4 individuals |
| Jul 2019 | Rights issue | ₹15 Lakh | Investors: 2 individuals |
| Nov 2018 | Funding round | ₹29 Lakh | Investors: 3 individuals |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Bioaltus Pharmaceuticals Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Bioaltus Pharmaceuticals Private Limited has 5 court cases on record: 3 filed by Bioaltus Pharmaceuticals, 2 filed against it. 1 case is pending and 4 are disposed.
Total cases
5
Filed by the company
3
Filed against the company
2
Pending
1
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 1 | 1 |
| High courts | 1 | 1 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Sun Pharmaceutical Industries Limited | Disposed |
| District court, Bhandara, Maharashtra | Civil suit | Filed against the company | Pending |
| District court, HAVERI, Karnataka | Criminal miscellaneous application | Filed by the company against an individual | Disposed |
| District court, Thane, Maharashtra | Civil suit | Filed by the company against an individual | Disposed |
| District court, Thane, Maharashtra | Civil suit | Filed by the company against M/S. Beloor Bayir Boitech Ltd and Other. and 5 others | Disposed |
To see the full case history of Bioaltus Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Bioaltus Pharmaceuticals Private Limited has 14 MSME Form 1 returns on record between 2019 and 2024, listing 3,547 overdue payments to 91 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 91)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Base Foils | |||
| D M Pharma | |||
| an individual supplier | |||
| an individual supplier | |||
| Mediraw Pharma & Nutra Private Limited |
To see the full MSME payment records of Bioaltus Pharmaceuticals Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Bioaltus Pharmaceuticals has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Bioaltus Lifesciences Private Limited | U21001MH2023PTC407189 |
To see the full group structure of Bioaltus Pharmaceuticals Private Limited, buy the company report.
Employees & EPFO
Bioaltus Pharmaceuticals Private Limited has a workforce of 33 employees on its EPFO records as of Mar 31, 2025, across 1 active EPFO establishment.
Employee count
33
Active EPFO establishments
1
Employee growth
17.86%
GST
Bioaltus Pharmaceuticals has 5 GST registrations: 5 active. The first 4 active GSTINs are listed below.
Total GSTINs
5
Active
5
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAFCB8840D1ZQ | Maharashtra | Active | 01 Jul 2017 |
| 02AAFCB8840D1Z2 | Himachal Pradesh | Active | 01 Jul 2017 |
| 11AAFCB8840D1Z3 | Sikkim | Active | 24 Nov 2020 |
| 05AAFCB8840D1ZW | Uttarakhand | Active | 20 Mar 2024 |
To see the full GST registrations and return filing status of Bioaltus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Bioaltus Pharmaceuticals Private Limited has 8 board changes on record since 2014: 2 appointments and 6 cessations. The latest: Devanshi Vijay Doshi ceased to be Additional Director on 30 Sep 2022.
AGM
Bioaltus Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 65.00 Cr registered on 15 May 2025 with Charge ID 101107796 was modified on 08 Jul 2025.
Charges
A charge registered on 31 Dec 2022 via Charge ID 100673869 with State Bank Of India was fully satisfied on 20 May 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 65.00 Cr with Charge ID 101107796 was registered on 15 May 2025.
Filing
Bioaltus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with State Bank Of India amounted to Rs. 7.50 Cr with Charge ID 100673869 was registered on 31 Dec 2022.
Charges
A charge registered on 13 Jan 2022 via Charge ID 100532554 with Others was fully satisfied on 14 Oct 2022.
Ceased
Devanshi Vijay Doshi ceased to be Additional Director.
Ceased
Mehul Pravin Shah ceased to be Director.
Charges
A charge registered on 19 May 2020 via Charge ID 100337501 with Others was fully satisfied on 12 Aug 2022.
Charges
A charge with Others amounted to Rs. 0.50 Cr with Charge ID 100532554 was registered on 13 Jan 2022.
Charges
A charge registered on 28 Sep 2018 via Charge ID 100217713 with Others was fully satisfied on 27 May 2021.
13 earlier events are in the company report.
Frequently asked questions
Bioaltus Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 March 2014 (12+ years old) and is registered under CIN U74900MH2014PTC254786.
Bioaltus Pharmaceuticals has 2 current directors:
- Ankit Varshney - Whole-Time Director
- Gopinath Ramankutty Nair - Whole-Time Director
The latest financial statements of Bioaltus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Bioaltus Pharmaceuticals is 27AAFCB8840D1ZQ, registered in Maharashtra. The company has 5 GST registrations in all, of which 5 are active. Other active GSTINs include 02AAFCB8840D1Z2 (Himachal Pradesh), 11AAFCB8840D1Z3 (Sikkim), 05AAFCB8840D1ZW (Uttarakhand).
The CIN (Corporate Identification Number) of Bioaltus Pharmaceuticals is U74900MH2014PTC254786. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bioaltus Pharmaceuticals has 5 court cases on record: 3 filed by the company and 2 filed against it. 1 is pending. Most are in the district courts.
Bioaltus Pharmaceuticals was incorporated on 21 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Mumbai.
Bioaltus Pharmaceuticals has 6 deals on record (2 rights issues, 2 funding rounds, 2 secondary share transfers), with disclosed funding of ₹7.77 Cr; the latest was in December 2021.
The peers of Bioaltus Pharmaceuticals by revenue are M J Biopharm Private Limited, Pell Tech Health Care Private Limited, Ronak Healthcare Private Limited, Zen Pharma Private Limited, Anglo-French Drugs & Industries Limited and 4 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Devanshi Vijay Doshi ceased to be Additional Director on 30 Sep 2022. Mehul Pravin Shah ceased to be Director on 25 Aug 2022. Ankit Varshney ceased to be Director on 06 Jan 2016. Bioaltus Pharmaceuticals has 8 board changes on record in total.
Yes, Bioaltus Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-33-0046060).
Bioaltus Pharmaceuticals has 14 MSME Form 1 returns on record between 2019 and 2024, listing 3,547 overdue payments to 91 micro and small suppliers. The latest return was filed on 01 May 2024.